Revolution Medicines

Replimune

Replimune develops oncolytic immunotherapies for cancer patients, including an approved viral treatment for adults with advanced, treatment-resistant melanoma.

Replimune Group

The company develops oncolytic immunotherapies for cancer patients, including its first commercial treatment for adults with advanced melanoma.

Pepper Therapeutics

This biotech company develops the drug phenformin as a treatment for pancreatic cancer to improve patient outcomes through affordable oncology therapies.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

Fore Biotherapeutics

This precision oncology company develops targeted therapies for patients with unaddressed cancer mutations, including a specific BRAF inhibitor for advanced solid tumours.

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.

Avistone Pharmaceuticals

The company develops and manufactures precision oncology medicines, specifically small-molecule targeted therapies for patients with lung cancer and other solid tumours.

Galera

This biopharmaceutical company develops small-molecule therapies to reduce the side effects of radiotherapy and improve treatment outcomes for patients with advanced breast cancer.